======= RWDD3 =======
== Gene Information ==
* **Official Symbol**: RWDD3
* **Official Name**: RWD domain containing 3
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25950|25950]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q9Y3V2|Q9Y3V2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=RWDD3&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20RWDD3|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/615875|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Enhancer of SUMO conjugation. Via its interaction with UBE2I/UBC9, increases SUMO conjugation to proteins by promoting the binding of E1 and E2 enzymes, thioester linkage between SUMO and UBE2I/UBC9 and transfer of SUMO to specific target proteins which include HIF1A, PIAS, NFKBIA, NR3C1 and TOP1. Isoform 1 and isoform 2 positively regulate the NF-kappa-B signaling pathway by enhancing the sumoylation of NF-kappa-B inhibitor alpha (NFKBIA), promoting its stabilization which consequently leads to an increased inhibition of NF-kappa-B transcriptional activity. Isoform 1 and isoform 2 negatively regulate the hypoxia-inducible factor-1 alpha (HIF1A) signaling pathway by increasing the sumoylation of HIF1A, promoting its stabilization, transcriptional activity and the expression of its target gene VEGFA during hypoxia. Isoform 2 promotes the sumoylation and transcriptional activity of the glucocorticoid receptor NR3C1 and enhances the interaction of SUMO1 and NR3C1 with UBE2I/UBC9. Has no effect on ubiquitination. {ECO:0000269|PubMed:17956732, ECO:0000269|PubMed:22009797, ECO:0000269|PubMed:23469069, ECO:0000269|PubMed:23508108}.
|RWD|
|DUF1115|
|regulation of hypoxia-inducible factor-1alpha signaling pathway|
|positive regulation of hypoxia-inducible factor-1alpha signaling pathway|
|positive regulation of cellular response to hypoxia|
|positive regulation of protein sumoylation|
|regulation of cellular response to hypoxia|
|regulation of protein sumoylation|
|negative regulation of NF-kappaB transcription factor activity|
|positive regulation of protein modification by small protein conjugation or removal|
|negative regulation of DNA-binding transcription factor activity|
|regulation of protein modification by small protein conjugation or removal|
|regulation of DNA-binding transcription factor activity|
|regulation of cellular response to stress|
|negative regulation of molecular function|
|positive regulation of protein modification process|
|regulation of response to stress|
|positive regulation of cellular protein metabolic process|
|positive regulation of signal transduction|
|positive regulation of protein metabolic process|
|positive regulation of cell communication|
|positive regulation of signaling|
|regulation of protein modification process|
\\
=== CRISPR Data ===
No hits were found.
No correlation found to any other genes in chemogenomics.
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 16130
* **Expression level (log2 read counts)**: 4.02
{{:chemogenomics:nalm6 dist.png?nolink |}}